Table 4.
Detailed genotypic analysis between NWNA and CUW and between NWNA and CUWA
| SNP | NWNA (n, %) | CUW (n, %) | ORa | NWNA (n, %) | CUWA (n, %) | ORa |
|---|---|---|---|---|---|---|
| BsmI | ||||||
| BB/Bb | 454 (71.9 %) | 141 (78.8 %) | 454 (71.9 %) | 43 (68.3 %) | ||
| bb | 177 (28.1 %) | 38 (21.2 %) | 0.70 (0.47–1.04) | 177 (28.1 %) | 20 (31.7 %) | 1.19 (0.68–2.09) |
| TaqI | ||||||
| TT/Tt | 549 (87.1 %) | 143 (80.8 %) | 549 (87.1 %) | 48 (78.7 %) | ||
| tt | 81 (12.9 %) | 34 (19.2 %) | 1.59 (1.02–2.50) | 81 (12.9 %) | 13 (21.3 %) | 1.80 (0.93–3.48) |
| ApaI | ||||||
| AA/Aa | 544 (85.9 %) | 159 (90.3 %) | 544 (85.9 %) | 53 (86.9 %) | ||
| aa | 89 (14.1 %) | 17 (9.7 %) | 0.66 (0.38–1.14) | 89 (14.1 %) | 8 (13.1 %) | 0.86 (0.41–1.94) |
aAdjusted for vitamin deficiency status (<20 ng/ml)